Impact of lifestyle and metformin therapy on cardiovascular (CVD) risk factors and events in the diabetes prevention program

被引：0
|
作者：
机构：
来源：
DIABETES | 2003年 / 52卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
下载
收藏
页码：A169 / A169
页数：1
相关论文
共 50 条
  • [21] Lifestyle and Metformin Treatment Favorably Influence Lipoprotein Subfraction Distribution in the Diabetes Prevention Program
    Goldberg, Ronald
    Temprosa, Marinette
    Otvos, James
    Arakaki, Richard
    Barrett-Connor, Elizabeth
    Haffner, Steven
    Horton, Edward
    Mather, Kieren
    Orchard, Trevor
    Watson, Karol
    CIRCULATION, 2009, 120 (18) : S442 - S442
  • [22] Lifestyle and Metformin Treatment Favorably Influence Lipoprotein Subfraction Distribution in the Diabetes Prevention Program
    Goldberg, R.
    Temprosa, M.
    Otvos, J.
    Brunzell, J.
    Marcovina, S.
    Mather, K.
    Arakaki, R.
    Watson, K.
    Horton, E.
    Barrett-Connor, E.
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2013, 98 (10): : 3989 - 3998
  • [23] Association of Intensive Lifestyle and Metformin Interventions With Frailty in the Diabetes Prevention Program Outcomes Study
    Hazuda, Helen P.
    Pan, Qing
    Florez, Hermes
    Luchsinger, Jose A.
    Crandall, Jill P.
    Venditti, Elizabeth M.
    Golden, Sherita H.
    Kriska, Andrea M.
    Bray, George A.
    JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES, 2021, 76 (05): : 929 - 936
  • [24] The Differential Impact of Medical Therapy and Lifestyle Modification on Cardiovascular Health and Risk of Adverse Cardiovascular Events: A Narrative Review
    Kolanu, Nikhil Deep
    Syeda, Zoya Riyaz
    Joshi, Nandan
    Singh, Prerna
    Erukulla, Mounika
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (04)
  • [25] Interaction of Diabetes Genetic Risk and Successful Lifestyle Modification in the Diabetes Prevention Program
    Raghavan, Sridharan
    Jablonski, Kathleen A.
    Delahanty, Linda M.
    Maruthur, Nisa
    Leong, Aaron
    Franks, Paul W.
    Knowler, William C.
    Florez, Jose C.
    Dabelea, Dana
    DIABETES, 2019, 68
  • [26] Cardiovascular risk factors may be altered by a structured lifestyle program
    Lidin, Matthias
    EUROPEAN JOURNAL OF CARDIOVASCULAR NURSING, 2019, 18 (08) : 764 - 764
  • [27] Thienopyridine therapy and risk for cardiovascular events in secondary prevention
    Peter P. Toth
    Annemarie Armani
    Current Atherosclerosis Reports, 2009, 11 : 364 - 370
  • [28] Thienopyridine therapy and risk for cardiovascular events in secondary prevention
    Toth, Peter P.
    Armani, Annemarie
    CURRENT ATHEROSCLEROSIS REPORTS, 2009, 11 (05) : 364 - 370
  • [29] Impact of canagliflozin combined with metformin therapy on reducing cardiovascular risk in type 2 diabetes patients
    Chen, Xiaoyu
    Shu, Yimin
    Lin, Xuebo
    DIABETOLOGY & METABOLIC SYNDROME, 2024, 16 (01):
  • [30] Sulfonylurea therapy is associated with greater risk of cardiovascular events compared to metformin
    Idris, Iskandar
    DIABETES OBESITY & METABOLISM, 2013, 15 (01): : 97 - 97
12345